ORC1A Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to ORC1A Antibody

The ORC1A antibody is a specialized immunological tool targeting the Origin Recognition Complex 1 (ORC1), a critical subunit of the origin recognition complex (ORC) essential for initiating DNA replication. ORC1 serves as a scaffold for assembling replication initiation factors and ensures precise genomic duplication during cell division. While most studies focus on ORC1 broadly, the term "ORC1A" specifically refers to isoforms or mutants identified in model organisms, such as Drosophila ORC1A, which has been pivotal in understanding DNA replication mechanics .

Antibody Characterization

The ORC1 Antibody (F-10) (Santa Cruz Biotechnology, sc-398734) is a widely cited monoclonal antibody with the following properties:

PropertyDetail
Host SpeciesMouse (IgG1 κ)
ApplicationsWestern Blot (WB), Immunoprecipitation (IP), Immunofluorescence (IF), ELISA
Target LocalizationNucleus (proliferating cells)
Conjugate OptionsAgarose, HRP, PE, FITC, Alexa Fluor®
Key FunctionsDetects ORC1 in DNA replication initiation, cell cycle regulation

This antibody recognizes human ORC1 and is instrumental in studying its interactions with other ORC subunits (ORC2–ORC6) and its dynamic chromatin binding during the G1-S transition .

Role in DNA Replication and Mutant Studies

  • Drosophila ORC1A Mutants: Overexpression of wild-type ORC1A in Drosophila induces ectopic DNA replication in quiescent cells, whereas the ORC1K604E mutant (defective in ATP hydrolysis) shows no phenotype. Biochemical analyses confirm that ATPase activity in ORC1A is critical for chromatin binding and replication initiation .

  • ATP-Dependent Mechanisms: ORC1’s AAA+ domain facilitates ATP hydrolysis, which modulates DNA binding. Mutations in Walker B motifs disrupt these functions, highlighting conserved mechanisms across species .

Clinical Relevance in Cancer

ORC1 is overexpressed in multiple tumors and correlates with poor prognosis and immune evasion:

  • Mechanistic Insights: ORC1 co-expresses with cell cycle regulators (CDCA3, PLK1) and associates with pathways like ATP binding and cell division .

Applications in Research

  • DNA Replication Studies: Used to map ORC1’s chromatin binding dynamics in Drosophila and human cells .

  • Cancer Diagnostics: Detects ORC1 overexpression in tumor tissues via immunohistochemistry (IHC), aiding in biomarker validation .

  • Functional Genomics: Characterizes ORC1 mutants (e.g., K604A) to dissect ATPase-dependent replication mechanisms .

Limitations and Future Directions

  • Species Specificity: Most antibodies, including F-10, are validated for human ORC1; cross-reactivity with ORC1A isoforms in other organisms (e.g., Drosophila) requires further study .

  • Therapeutic Potential: While ORC1 is a promising cancer target, its role in immune modulation remains unclear, necessitating functional studies in diverse tumor microenvironments .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ORC1A antibody; At4g14700 antibody; dl3390w antibody; FCAALL.93 antibody; Origin of replication complex subunit 1A antibody; AtORC1a antibody; Origin recognition complex subunit 1a antibody
Target Names
ORC1A
Uniprot No.

Target Background

Function
ORC1A is an essential protein that serves as a component of the origin recognition complex (ORC). This complex plays a crucial role in binding to origins of replication, initiating both chromosomal replication and mating type transcriptional silencing. ORC1A specifically interacts with the ARS consensus sequence (ACS) of origins of replication. Furthermore, it acts as an H3K4me3 effector, positively regulating the transcription of a specific subset of genes.
Gene References Into Functions
  1. ORC1a and ORC1b are regulated by the E2F/DP family of transcription factors, with AtORC1a exhibiting preferential expression in endoreplicating cells. [ORC1a] PMID: 16179646
  2. ORC1 and Mcm3 proteins are essential for DNA replication in protein extracts derived from human cells. PMID: 16537544
  3. ORC1 functions as a transcriptional activator of a specific set of genes. The promoters of these genes exhibit preferential binding by ORC1. PMID: 19171893
Database Links

KEGG: ath:AT4G14700

STRING: 3702.AT4G14700.1

UniGene: At.25357

Protein Families
ORC1 family
Subcellular Location
Nucleus.
Tissue Specificity
Follow a cell-cycle regulation with a peak at the G1/S-phase. Mostly expressed in siliques, flowers and flower buds, and, to a lower extent, in roots, leaves and stems.

Q&A

What is ORC1A and why is it important in plant research?

ORC1A is one of two Origin Recognition Complex 1 proteins found in Arabidopsis thaliana (the other being ORC1B). While these proteins share structural similarities, they have distinct functions and expression patterns. ORC1A appears to be restricted to endoreplicating cells and plays a crucial role in heterochromatin maintenance by facilitating the deposition of H3K27me1 by the ATXR5/6 methyltransferases . Unlike its paralog ORC1B, which functions primarily in DNA replication during the cell cycle, ORC1A specifically contributes to heterochromatin organization and genome stability . This functional specialization makes ORC1A a valuable target for researchers studying chromatin dynamics, endoreplication, and epigenetic regulation in plants.

How can I validate the specificity of an ORC1A antibody?

Validating antibody specificity is critical, especially when working with proteins that have close paralogs like ORC1A and ORC1B. A comprehensive validation approach includes:

  • Western blot analysis: Compare wild-type plants with orc1a knockout mutants to confirm absence of the band in mutants. Cross-reactivity with ORC1B should be assessed using recombinant proteins or known ORC1B-overexpressing lines.

  • Immunofluorescence microscopy: ORC1A-GFP has been shown to localize predominantly to heterochromatic chromocenters in endoreplicating cells . Validate your antibody by confirming similar localization patterns and by using orc1a mutants as negative controls.

  • Peptide competition assay: Pre-incubate the antibody with the immunizing peptide before performing immunostaining or Western blot to confirm signal reduction.

  • Epitope mapping: Ensure the antibody targets regions that differ between ORC1A and ORC1B to minimize cross-reactivity.

Remember that co-staining with heterochromatin markers like H3K9me2 and DAPI can provide additional confirmation, as ORC1A has been demonstrated to colocalize with chromocenters .

What are the recommended storage and handling conditions for ORC1A antibodies?

Based on standard protocols for similar antibodies:

  • Store at -20°C in aliquots to avoid repeated freeze-thaw cycles

  • Most commercial antibodies come in buffered aqueous glycerol solutions that help maintain stability

  • When working with the antibody, keep it on ice and return to -20°C promptly after use

  • For long-term storage (>1 year), consider storing small working aliquots to prevent contamination of the stock

Prior to use, centrifuge the antibody vial briefly to collect the solution at the bottom of the tube. For dilutions, use buffers recommended by the manufacturer, typically PBS with BSA or normal serum from the same species as the secondary antibody.

How should I optimize immunofluorescence protocols for ORC1A detection in plant tissues?

Optimizing immunofluorescence for ORC1A detection requires consideration of its unique properties:

Recommended Protocol:

  • Fixation: Use 4% paraformaldehyde in PBS for 20-30 minutes, as overfixation may mask the epitope

  • Permeabilization: Treat with 0.1% Triton X-100 for 10 minutes

  • Blocking: 3% BSA in PBS with 0.05% Tween-20 for 1 hour

  • Primary antibody: Dilute according to manufacturer specifications (typically 0.25-2 μg/mL for immunofluorescence)

  • Washing: 3 × 5 minutes with PBS containing 0.05% Tween-20

  • Secondary antibody: Use species-appropriate fluorophore-conjugated secondary

  • Chromatin counterstaining: DAPI at 1 μg/mL

  • Co-staining: Include H3K9me2 antibody to mark heterochromatin regions for colocalization assessment

Optimization tips:

  • Test a range of antibody concentrations (0.1-5 μg/mL)

  • Consider antigen retrieval techniques if signal is weak

  • Include wild-type and orc1a mutant tissues as positive and negative controls

  • For root tissues, focus on the transition and elongation zones where ORC1A is more abundantly expressed

How can I distinguish between ORC1A and ORC1B signals in my experiments?

Distinguishing between these paralogous proteins requires careful experimental design:

Method 1: Spatial and temporal expression patterns

  • ORC1A is primarily expressed in endoreplicating cells in the transition zone prior to exit to differentiation

  • ORC1B is detected in both proliferating cells in the RAM and endoreplicating cells in the transition zone

  • In proliferating zones, 90.9% of cells lack ORC1A-GFP while only 49.7% lack ORC1B-GFP

Method 2: Subcellular localization

  • ORC1A shows a distinct punctate pattern (48.5% of positive nuclei) corresponding to chromocenters

  • ORC1B can appear punctate, homogeneously distributed, or both

Method 3: Proteasome inhibition test

  • Treatment with proteasome inhibitors (bortezomib) or CRL inhibitors (MLN4924) does not affect ORC1A levels

  • The same treatments significantly increase ORC1B levels

Method 4: Co-immunoprecipitation profiles

  • ORC1A co-precipitates with heterochromatin-associated proteins like ATXR5/6

  • ORC1B co-precipitates with pre-replication complex components

Using these differential characteristics will help ensure accurate identification of your target protein.

What controls should I include when performing Western blots with ORC1A antibodies?

A robust Western blot experiment for ORC1A should include the following controls:

  • Positive control: Wild-type Arabidopsis tissue (preferably enriched for endoreplicating cells)

  • Negative control: orc1a knockout mutant tissue

  • Specificity control: Recombinant ORC1A protein or ORC1A-overexpressing line

  • Cross-reactivity control: Recombinant ORC1B protein or ORC1B-overexpressing line

  • Loading control: Antibody against a constitutively expressed protein (e.g., actin, tubulin)

  • Size reference: Pre-stained molecular weight marker

Additional validation approaches:

  • Peptide competition assay: Pre-incubate antibody with immunizing peptide

  • Multiple antibodies test: If available, use antibodies targeting different epitopes of ORC1A

  • Gradient gel analysis: To better resolve ORC1A from similar molecular weight proteins

Control TypeSampleExpected ResultPurpose
Positive controlWild-type tissueBand at predicted MWConfirms antibody functionality
Negative controlorc1a knockoutNo bandConfirms specificity
Specificity controlRecombinant ORC1AStrong band at predicted MWValidates target recognition
Cross-reactivity controlRecombinant ORC1BNo or minimal bandAssesses paralog discrimination
Loading controlAny sampleConsistent bandsNormalizes protein loading

How can ORC1A antibodies be used to investigate heterochromatin maintenance mechanisms?

ORC1A antibodies serve as powerful tools for investigating heterochromatin maintenance through several advanced approaches:

  • Chromatin Immunoprecipitation (ChIP):

    • Use ORC1A antibodies for ChIP followed by sequencing (ChIP-seq) to map ORC1A binding sites genome-wide

    • Compare with H3K27me1 and H3K9me2 ChIP-seq data to correlate ORC1A localization with specific heterochromatin marks

    • Analysis of wild-type vs. atxr5/6 mutants can reveal dependency relationships between ORC1A binding and histone methyltransferase activity

  • Co-immunoprecipitation (Co-IP):

    • Identify ORC1A-interacting proteins by Co-IP followed by mass spectrometry

    • Validate interactions with known heterochromatin proteins (e.g., ATXR5/6)

    • Compare interaction profiles between wild-type and mutant backgrounds (e.g., orc1a-2, atxr5/6)

  • Proximity Ligation Assay (PLA):

    • Visualize and quantify interactions between ORC1A and potential partners in situ

    • Especially valuable for detecting transient or context-dependent interactions

  • Immunofluorescence combined with quantitative image analysis:

    • Measure the relative heterochromatin fraction (RHF) in different genetic backgrounds

    • Quantify colocalization of ORC1A with H3K27me1 and H3K9me2

    • Track changes in heterochromatin organization during development or in response to stress

Research using these approaches has revealed that orc1a-2 mutants show a reduction in RHF similar to atxr5/6 mutants, while orc1b-2 mutants show no significant differences compared to wild type . This supports ORC1A's specific role in heterochromatin maintenance.

What approaches can resolve contradictory results when studying ORC1A functions?

When faced with contradictory results regarding ORC1A functions, consider these methodological approaches:

  • Genetic complementation tests:

    • Transform orc1a mutants with ORC1A-GFP fusion constructs under native promoter

    • Quantify rescue of heterochromatin phenotypes (e.g., restoration of RHF)

    • Published data shows orc1a-2,ORC1A-GFP plants restored wild-type RHF levels

  • Domain swap experiments:

    • Create chimeric proteins containing domains from ORC1A and ORC1B

    • Determine which domains confer heterochromatin maintenance vs. replication functions

    • Test if ORC1A's unique functions can be transferred to ORC1B through specific domains

  • Cell-type specific analyses:

    • Use fluorescence-activated cell sorting (FACS) to isolate specific cell populations

    • Compare ORC1A levels and functions in proliferating vs. endoreplicating cells

    • This addresses potential cell-type specific differences that might explain contradictory results

  • Multiple mutation alleles:

    • Compare phenotypes across different orc1a alleles (e.g., T-DNA insertions, CRISPR/Cas9 knockouts)

    • Determine if contradictions are due to allele-specific effects (e.g., hypomorphic vs. null)

  • Conditional systems:

    • Use inducible degradation or expression systems for ORC1A

    • Separate immediate vs. long-term adaptation effects

    • Distinguish primary from secondary phenotypes

When analyzing contradictory results, consider that ORC1A functions differently in distinct cellular contexts. For example, its role may be most evident in endoreplicating cells with high heterochromatin content, rather than in actively dividing cells where ORC1B predominates .

How can I analyze changes in ORC1A-associated heterochromatin during developmental transitions?

Analyzing ORC1A-associated heterochromatin dynamics during development requires integrating multiple techniques:

  • Time-course developmental analysis:

    • Sample tissues at defined developmental stages

    • Track ORC1A localization, abundance, and associated heterochromatin markers

    • Focus on transition zones where cells shift from proliferation to endoreplication

  • Fluorescent reporter systems:

    • Use ORC1A-GFP expressed under its native promoter to monitor expression patterns

    • Combine with cell-cycle reporters (e.g., CDT1-RFP) to correlate with endocycle progression

    • Implement a Rainbow Female gametophyte cassette or similar marker systems to facilitate phenotypic characterization

  • Quantitative image analysis:

    • Measure chromocenter size, number, and intensity in different developmental zones

    • Calculate relative heterochromatin fraction (RHF) as the ratio of DAPI-stained chromocenter area to total nuclear area

    • Track H3K27me1 and H3K9me2 mark distribution alongside ORC1A localization

  • Single-cell transcriptomics and proteomics:

    • Correlate ORC1A protein levels with gene expression profiles in individual cells

    • Identify co-expression modules associated with heterochromatin formation

    • Map developmental trajectories showing transitions in chromatin state

  • Live-cell imaging:

    • Track ORC1A-GFP dynamics during developmental transitions

    • Measure residence time on chromatin using techniques like FRAP (Fluorescence Recovery After Photobleaching)

    • Visualize changes in chromocenter organization in real-time

Research has shown that ORC1A is specifically detected in endoreplicating cells prior to exit to differentiation, suggesting a developmental window where its function is most critical . Analyzing these transitions can reveal mechanisms by which cells establish stable heterochromatin domains during differentiation.

Why might I observe weak or non-specific signals when using ORC1A antibodies?

Several factors can contribute to weak or non-specific signals when working with ORC1A antibodies:

Potential Issues and Solutions:

  • Low abundance of ORC1A protein:

    • ORC1A is cell-type specific, present primarily in endoreplicating cells

    • 90.9% of cells in the proliferation zone and 30.2% in the transition/elongation zones lack detectable ORC1A-GFP

    • Solution: Enrich for endoreplicating cells in your sample preparation

  • Cross-reactivity with ORC1B:

    • ORC1A and ORC1B share sequence similarities

    • Solution: Validate antibody specificity using recombinant proteins and knockout mutants

    • Consider using peptide competition assays to confirm specificity

  • Suboptimal fixation affecting epitope availability:

    • Solution: Test multiple fixation protocols (PFA, methanol, acetone)

    • Try antigen retrieval methods if necessary

  • Insufficient blocking:

    • Solution: Increase blocking reagent concentration (e.g., 5% BSA or 10% normal serum)

    • Extend blocking time to 2 hours or overnight at 4°C

  • Secondary antibody issues:

    • Solution: Test alternative secondary antibodies

    • Include secondary-only controls to assess background

ProblemPotential CauseSolution
No signalInsufficient proteinIncrease sample concentration; enrich for endoreplicating cells
No signalEpitope maskedTry different fixation methods; use antigen retrieval
Multiple bandsCross-reactivityValidate with knockouts; use more stringent washing
High backgroundInsufficient blockingIncrease blocking reagent; include detergent in wash buffers
Inconsistent resultsAntibody degradationUse fresh aliquots; avoid freeze-thaw cycles

How can I design experiments to distinguish between direct and indirect effects of ORC1A on heterochromatin?

Distinguishing direct from indirect effects requires carefully designed experiments:

  • Rapid-response systems:

    • Use inducible degradation systems (AID/TIR1) to rapidly remove ORC1A protein

    • Monitor immediate changes in heterochromatin organization before secondary effects occur

    • Compare with long-term depletion phenotypes

  • Structure-function analysis:

    • Generate point mutations in key functional domains of ORC1A

    • Test effects on protein-protein interactions and heterochromatin maintenance

    • Identify separation-of-function mutations that affect specific aspects of ORC1A activity

  • In vitro reconstitution:

    • Reconstitute heterochromatin formation using purified components

    • Test if ORC1A directly facilitates H3K27me1 deposition by ATXR5/6

    • Determine minimal components required for this function

  • Genomic footprinting:

    • Map ORC1A binding sites at high resolution using techniques like CUT&RUN

    • Correlate with changes in heterochromatin marks

    • Establish temporal order of events (ORC1A binding → histone modification → chromatin compaction)

  • Genetic interaction studies:

    • Compare phenotypes of single and double mutants (e.g., orc1a, atxr5/6, orc1a/atxr5/6)

    • Determine if genes act in the same or parallel pathways

    • Research has shown that orc1a-2, atxr5/6 and orc1a-2,atxr5/6 all showed reductions in RHF, supporting the hypothesis that they function in the same pathway

What are the key considerations when designing a ChIP-seq experiment with ORC1A antibodies?

A successful ChIP-seq experiment for ORC1A requires careful planning:

  • Antibody selection and validation:

    • Confirm specificity for ORC1A over ORC1B using knockout controls

    • Validate for ChIP applications specifically (not all IF or WB antibodies work well in ChIP)

    • Consider using epitope-tagged ORC1A (e.g., ORC1A-GFP) with ChIP-validated GFP antibodies as an alternative

  • Sample preparation:

    • Enrich for tissues/cells with high ORC1A expression (endoreplicating cells)

    • Optimize crosslinking conditions (typically 1% formaldehyde for 10 minutes)

    • Ensure efficient chromatin fragmentation (200-500 bp fragments)

  • Controls and normalization:

    • Include input control, IgG control, and orc1a mutant negative control

    • Use spike-in normalization with a foreign genome (e.g., Drosophila chromatin) for quantitative comparisons

  • Data analysis considerations:

    • Use peak calling algorithms optimized for heterochromatin regions

    • Compare with H3K27me1 and H3K9me2 ChIP-seq data

    • Analyze repeat regions and transposable elements carefully (often overlooked in standard pipelines)

  • Validation of ChIP-seq findings:

    • Confirm key peaks by ChIP-qPCR

    • Perform sequential ChIP (re-ChIP) to identify regions with co-occurring marks

    • Use orthogonal techniques (e.g., DNA methylation analysis) to validate heterochromatin state

ORC1A ChIP-seq experiments should focus particularly on heterochromatic regions, as ORC1A has been shown to preferentially localize to chromocenters and play a role in heterochromatin maintenance .

How can new antibody engineering techniques improve ORC1A-specific research tools?

Recent advances in antibody engineering offer promising approaches to create better ORC1A research tools:

  • Phage display technology:

    • Enables selection of antibodies with customized specificity profiles

    • Can generate antibodies that specifically recognize ORC1A over ORC1B

    • Allows for identifying different binding modes associated with particular epitopes

  • Computational design of antibodies:

    • Biophysics-informed modeling can predict antibody-antigen interactions

    • Machine learning approaches can optimize antibody sequences for desired properties

    • Recent research demonstrates successful computational design of antibodies with customized specificity profiles

  • Nanobodies and single-domain antibodies:

    • Smaller size enables better penetration into dense heterochromatin

    • Can be expressed intracellularly as "intrabodies" for live-cell imaging

    • Potentially higher stability and specificity for challenging epitopes

  • Bispecific antibodies:

    • Recognize both ORC1A and another heterochromatin marker simultaneously

    • Increase specificity through avidity effects

    • Enable super-resolution imaging of ORC1A in heterochromatin contexts

  • Proximity labeling antibody conjugates:

    • Antibodies conjugated to enzymes like APEX2 or TurboID

    • Enable mapping of the local ORC1A interaction network in intact cells

    • Provide spatial context to protein-protein interactions

These emerging technologies can help overcome current limitations in studying ORC1A, particularly for distinguishing it from ORC1B and for visualizing its dynamics in heterochromatin contexts.

What are the latest findings on ORC1A's role in genome stability and plant development?

Recent research has revealed several important aspects of ORC1A function:

  • Heterochromatin organization:

    • ORC1A facilitates the deposition of H3K27me1 by the ATXR5/6 methyltransferases

    • Loss of ORC1A leads to reduction in relative heterochromatin fraction (RHF)

    • ORC1A preferentially localizes to heterochromatic chromocenters in endoreplicating cells

  • Distinct functions from ORC1B:

    • While ORC1B is cell cycle regulated and involved in DNA replication, ORC1A appears to be restricted to endoreplicating cells

    • ORC1A is not targeted for proteasome degradation, unlike ORC1B

    • The two proteins have different expression domains and subnuclear localization patterns

  • Cell-type specificity:

    • ORC1A is primarily expressed in endoreplicating cells prior to exit to differentiation

    • 90.9% of cells in the proliferation zone lack ORC1A-GFP, while 48.5% of positive nuclei in transition/elongation zones show a punctate pattern

  • Conservation and evolution:

    • Unlike metazoans, which have a single ORC1 protein with dual functions, plants have evolved specialized ORC1 paralogs

    • This specialization may reflect the importance of endoreplication in plant development

  • Functional redundancy:

    • Despite their distinct roles, some functional redundancy may exist between ORC1A and ORC1B

    • This could explain why single mutants show relatively mild phenotypes under standard growth conditions

These findings highlight ORC1A's specialized role in maintaining heterochromatin integrity during plant development, particularly in endoreplicating cells transitioning to differentiation.

How might ORC1A antibodies contribute to understanding broader questions in plant epigenetics?

ORC1A antibodies can serve as valuable tools for addressing fundamental questions in plant epigenetics:

  • Mechanisms of heterochromatin formation and maintenance:

    • Track ORC1A localization during development to understand when and how heterochromatin domains are established

    • Investigate the relationship between DNA replication, heterochromatin formation, and endoreplication

    • Explore ORC1A's role in recruiting or stabilizing histone modifiers like ATXR5/6

  • Responses to environmental stresses:

    • Monitor changes in ORC1A localization and heterochromatin organization under different stress conditions

    • Investigate whether stress-induced chromatin remodeling involves ORC1A

    • Study potential epigenetic memory mechanisms involving ORC1A-dependent heterochromatin

  • Developmental transitions and cell fate determination:

    • Examine how changes in heterochromatin organization correlate with developmental transitions

    • Investigate whether ORC1A-dependent heterochromatin affects gene expression during differentiation

    • Study the relationship between endoreplication, heterochromatin formation, and cell fate decisions

  • Evolution of epigenetic regulation:

    • Compare ORC1A functions across different plant species

    • Investigate how the specialization of ORC1 proteins evolved in plants

    • Study whether ORC1A-like proteins play similar roles in other organisms with extensive endoreplication

  • Genome stability and transposon silencing:

    • Examine ORC1A's role in silencing transposable elements

    • Investigate connections between heterochromatin maintenance and genome stability

    • Study how endoreplication affects genome integrity through ORC1A-dependent mechanisms

By developing and applying ORC1A-specific antibodies to these research areas, scientists can gain deeper insights into the fundamental mechanisms of epigenetic regulation in plants and potentially discover new principles applicable to other organisms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.